Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0S8KA
|
||||
| Former ID |
DNC004125
|
||||
| Drug Name |
3-(2-Amino-propyl)-1H-indol-5-ol
|
||||
| Synonyms |
5-hydroxy-alpha-methyltryptamine
|
||||
| Indication | Discovery agent | Investigative | [527952] | ||
| Canonical SMILES |
CC(CC1=CNC2=C1C=C(C=C2)O)N
|
||||
| InChI |
1S/C11H14N2O/c1-7(12)4-8-6-13-11-3-2-9(14)5-10(8)11/h2-3,5-7,13-14H,4,12H2,1H3
|
||||
| InChIKey |
LYPCGXKCQDYTFV-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527952] | |
| 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527952] | ||
| 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527952] | ||
| 5-hydroxytryptamine 1A receptor | Target Info | Inhibitor | [526713] | ||
| WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
| SIDS Susceptibility Pathways | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP722:Serotonin HTR1 Group and FOS Pathway | |||||
| References | |||||
| Ref 526713 | J Med Chem. 2003 Sep 11;46(19):4188-95.A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole. | ||||
| Ref 527952 | J Med Chem. 2006 Jan 12;49(1):318-28.1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.